Medifast Inc.
MED | NYSE
$12.26
+$0.49 (+4.16%)
At close: Sep 21, 2026, 4:00 PM ET
$12.26
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 385.79M | 602.46M | 1.07B | 1.6B | 1.53B | 934.84M |
Cost of Revenue | 110.6M | 157.84M | 296.2M | 458.16M | 398.49M | 237.03M |
Gross Profit | 275.19M | 444.62M | 775.85M | 1.14B | 1.13B | 697.82M |
Operating Income | -14.21M | 2.88M | 126.4M | 184.81M | 216.24M | 134.16M |
Interest Income | 5.52M | 4.8M | 2.49M | n/a | n/a | 246K |
Pretax Income | -5.64M | 3.79M | 128.8M | 184.06M | 216.13M | 134.27M |
Net Income | -18.67M | 2.09M | 99.42M | 143.57M | 164.03M | 102.86M |
Selling & General & Admin | 289.4M | 441.75M | 649.45M | 955.61M | 911.36M | 563.66M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 289.4M | 441.75M | 649.45M | 955.61M | 911.36M | 563.66M |
Interest Expense | n/a | n/a | n/a | 701K | 231K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 400M | 599.59M | 945.65M | 1.41B | 1.31B | 800.68M |
Income Tax Expense | 13.03M | 1.7M | 29.38M | 40.49M | 52.1M | 31.41M |
Shares Outstanding (Basic) | 10.98M | 10.93M | 10.88M | 11.2M | 11.71M | 11.77M |
Shares Outstanding (Diluted) | 10.98M | 10.96M | 10.92M | 11.28M | 11.81M | 11.85M |
EPS (Basic) | -1.70 | 0.19 | 9.10 | 12.82 | 14.01 | 8.74 |
EPS (Diluted) | -1.70 | 0.19 | 9.10 | 12.73 | 13.89 | 8.68 |
EBITDA | 4.86M | 16.49M | 141.9M | 195.74M | 222.94M | 138.48M |
EBIT | -5.64M | 3.79M | 128.8M | 184.76M | 216.13M | 134.16M |
Depreciation & Amortization | 10.5M | 12.71M | 13.11M | 10.98M | 6.81M | 4.32M |
Add to Watchlist
Select watchlists to add or remove MED